IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury

Introduction: Patients with severe fibrosis or cirrhosis are at high risk for liver-related complications, even after successful antiviral treatment and/or regression of fibrosis. These are the first published results concerning the role of IL-28B genotypes as predictors of the durability of sustai...

Full description

Saved in:
Bibliographic Details
Main Authors: Jelena Jordovic, Jasmina Simonovic-Babic, Vladimir Gasic, Nikola Kotur, Branka Zukic, Sonja Pavlovic, Ivana Lazarevic, Danijela Karalic, Natasa Katanic, Natasa Nikolic, Aleksandar Urosevic, Jelena Nestorov, Dragan Delic, Ksenija Bojovic
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2019-05-01
Series:Journal of Infection in Developing Countries
Subjects:
Online Access:https://jidc.org/index.php/journal/article/view/11351
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849313709290160128
author Jelena Jordovic
Jasmina Simonovic-Babic
Vladimir Gasic
Nikola Kotur
Branka Zukic
Sonja Pavlovic
Ivana Lazarevic
Danijela Karalic
Natasa Katanic
Natasa Nikolic
Aleksandar Urosevic
Jelena Nestorov
Dragan Delic
Ksenija Bojovic
author_facet Jelena Jordovic
Jasmina Simonovic-Babic
Vladimir Gasic
Nikola Kotur
Branka Zukic
Sonja Pavlovic
Ivana Lazarevic
Danijela Karalic
Natasa Katanic
Natasa Nikolic
Aleksandar Urosevic
Jelena Nestorov
Dragan Delic
Ksenija Bojovic
author_sort Jelena Jordovic
collection DOAJ
description Introduction: Patients with severe fibrosis or cirrhosis are at high risk for liver-related complications, even after successful antiviral treatment and/or regression of fibrosis. These are the first published results concerning the role of IL-28B genotypes as predictors of the durability of sustained virological response (SVR) and long-term outcome, in patients with baseline severe fibrosis and cirrhosis caused by hepatitis C (HCV) infection. Methodology: Genetic testing for three different single nucleotide polymorphisms (SNP) near the IL28B gene, rs12979860, rs12980275 and rs8099917, was performed in 42 patients with HCV-related advanced fibrosis and cirrhosis, who achieved SVR after successful interferon-based treatment. Baseline clinical and laboratory parameters were analysed, as well as IL28B genotype association with late virological relapse, fibrosis progression and clinical outcomes. Results: The most prevalent genotypes in all three tested SNP positions were: CCrs12979860 genotype in 69% of patients, GTrs8099917 in 78.6% and GGrs12980275 in 47.6% of patients. The presence of IL28B CCrs12979860 genotype was identified as a negative predictor of late virological relapse. Further analysis did not confirm the association of other IL28B genotypes with the progression of fibrosis and clinical outcomes. Conclusions: Varying long-term prognosis in patients with HCV-related severe fibrosis and cirrhosis is due to multiple interactions between host genetic factors, virus and environment. These are first published results demonstrating the significance of IL28B CCrs12979860 genotype as a negative predictor of late virological relapse. A further investigation concerning genetic factors is necessary to identify patients under risk for late relapse, complications and unfavorable outcomes, so that they can be reevaluated and offered new treatment options.
format Article
id doaj-art-103f2eb8c1bb43bb817f04e4795c48bc
institution Kabale University
issn 1972-2680
language English
publishDate 2019-05-01
publisher The Journal of Infection in Developing Countries
record_format Article
series Journal of Infection in Developing Countries
spelling doaj-art-103f2eb8c1bb43bb817f04e4795c48bc2025-08-20T03:52:42ZengThe Journal of Infection in Developing CountriesJournal of Infection in Developing Countries1972-26802019-05-01130610.3855/jidc.11351IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injuryJelena Jordovic0Jasmina Simonovic-Babic1Vladimir Gasic2Nikola Kotur3Branka Zukic4Sonja Pavlovic5Ivana Lazarevic6Danijela Karalic7Natasa Katanic8Natasa Nikolic9Aleksandar Urosevic10Jelena Nestorov11Dragan Delic12Ksenija Bojovic13Clinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, SerbiaClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, SerbiaLaboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, SerbiaLaboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, BelgradeLaboratory for Molecular Biomedicine, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, BelgradeMedical Faculty, University of Belgrade, Belgrade, SerbiaInstitute of Microbiology and Immunology, Belgrade, SerbiaInstitute of Microbiology and Immunology, Belgrade, SerbiaClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, SerbiaClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, SerbiaClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, SerbiaMedical Faculty, University of Belgrade, Belgrade, SerbiaClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, SerbiaClinic for Infectious and Tropical Diseases, Clinical Centre of Serbia, Belgrade, Serbia Introduction: Patients with severe fibrosis or cirrhosis are at high risk for liver-related complications, even after successful antiviral treatment and/or regression of fibrosis. These are the first published results concerning the role of IL-28B genotypes as predictors of the durability of sustained virological response (SVR) and long-term outcome, in patients with baseline severe fibrosis and cirrhosis caused by hepatitis C (HCV) infection. Methodology: Genetic testing for three different single nucleotide polymorphisms (SNP) near the IL28B gene, rs12979860, rs12980275 and rs8099917, was performed in 42 patients with HCV-related advanced fibrosis and cirrhosis, who achieved SVR after successful interferon-based treatment. Baseline clinical and laboratory parameters were analysed, as well as IL28B genotype association with late virological relapse, fibrosis progression and clinical outcomes. Results: The most prevalent genotypes in all three tested SNP positions were: CCrs12979860 genotype in 69% of patients, GTrs8099917 in 78.6% and GGrs12980275 in 47.6% of patients. The presence of IL28B CCrs12979860 genotype was identified as a negative predictor of late virological relapse. Further analysis did not confirm the association of other IL28B genotypes with the progression of fibrosis and clinical outcomes. Conclusions: Varying long-term prognosis in patients with HCV-related severe fibrosis and cirrhosis is due to multiple interactions between host genetic factors, virus and environment. These are first published results demonstrating the significance of IL28B CCrs12979860 genotype as a negative predictor of late virological relapse. A further investigation concerning genetic factors is necessary to identify patients under risk for late relapse, complications and unfavorable outcomes, so that they can be reevaluated and offered new treatment options. https://jidc.org/index.php/journal/article/view/11351interleukine 28Blate relapseoutcome
spellingShingle Jelena Jordovic
Jasmina Simonovic-Babic
Vladimir Gasic
Nikola Kotur
Branka Zukic
Sonja Pavlovic
Ivana Lazarevic
Danijela Karalic
Natasa Katanic
Natasa Nikolic
Aleksandar Urosevic
Jelena Nestorov
Dragan Delic
Ksenija Bojovic
IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
Journal of Infection in Developing Countries
interleukine 28B
late relapse
outcome
title IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
title_full IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
title_fullStr IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
title_full_unstemmed IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
title_short IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
title_sort il 28b genotypes as predictors of long term outcome in patients with hepatitis c related severe liver injury
topic interleukine 28B
late relapse
outcome
url https://jidc.org/index.php/journal/article/view/11351
work_keys_str_mv AT jelenajordovic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT jasminasimonovicbabic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT vladimirgasic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT nikolakotur il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT brankazukic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT sonjapavlovic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT ivanalazarevic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT danijelakaralic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT natasakatanic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT natasanikolic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT aleksandarurosevic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT jelenanestorov il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT dragandelic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury
AT ksenijabojovic il28bgenotypesaspredictorsoflongtermoutcomeinpatientswithhepatitiscrelatedsevereliverinjury